Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2000
03/07/2000US6034060 Peptide having an ability to promote the activation of protein C by thrombin
03/07/2000US6033917 Method for the preparation of free radical pharmaceuticals, diagnostics and devices using selenium conjugates
03/07/2000US6033910 Antisense inhibition of MAP kinase kinase 6 expression
03/07/2000US6033905 Gibbon ape leukemia virus-based retroviral vectors
03/07/2000US6033847 InK4c-p18 and InK4d-p19, inhibitors of cyclin-dependent kinases CDK4 and CDK6, and uses thereof
03/07/2000US6033688 Cystic fibrosis therapy
03/07/2000US6033687 Blend of long lag and short lag pellets
03/07/2000US6033686 Controlled release tablet of bupropion hydrochloride
03/07/2000US6033685 Tablet for the controlled release of active agents
03/07/2000US6033682 S(+) desmethylselegiline and its use in therapeutic methods and pharmaceutical compositions
03/07/2000US6033669 Methods for generating cytotoxic T cells and treatment of diseases thereby
03/07/2000US6033662 Oxygen activatable formulations for disinfection or sterilization
03/07/2000US6033656 Method of preventing or alleviating mammalian obesity
03/07/2000US6033655 Prepared by contacting a magnetic iron metal species with an ion exchange resin under conditions which permit binding between the metal and the resin
03/07/2000CA2195093C Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity
03/07/2000CA2136706C Process for controlling adiposity and compositions for use therein
03/07/2000CA2117679C Novel cephalosporin antibiotics and processes for the preparation thereof
03/07/2000CA2108804C Cosmetic or dermato-pharmaceutical composition containing a basic amino acid lauroylmethionate associated with at least a polyphenol
03/07/2000CA2030401C Inhibition of the abstinence syndrome
03/07/2000CA2013966C Active specific immunotherapy of adenocarcinomas producing immunosuppressive mucins
03/07/2000CA2007935C Aromatic keto compounds, the preparation thereof, and drugs and cosmetics containing these
03/07/2000CA2001168C Substituted 2-aminothiazoles
03/07/2000CA1340918C Macrolide compounds
03/02/2000WO2000011276A1 Elephant-nosed toilet plunger
03/02/2000WO2000011207A1 USE OF mCRP FOR DELIVERY OF MATERIALS INTO CELLS
03/02/2000WO2000011195A1 C-myc is activated by beta-catenin and tcf-4
03/02/2000WO2000011191A2 Tpl-2/cot kinase and methods of use
03/02/2000WO2000011033A2 Expression and export of angiostatin and endostatin as immunofusins
03/02/2000WO2000011019A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agent
03/02/2000WO2000011018A1 Conjugates of dna interacting groups with steroid hormones for use as nucleic acid transfection agents
03/02/2000WO2000011011A1 3'-desoxypentopyranosyl nucleic acid, its production and its use
03/02/2000WO2000011010A1 Phosphoglycolipid and methods for its use
03/02/2000WO2000011001A1 Muscarinic agonists and antagonists
03/02/2000WO2000011000A2 New compounds
03/02/2000WO2000010999A2 New compounds
03/02/2000WO2000010997A1 Pyridyl ethers and thioethers as ligands for nicotinic acetylcholine receptor and its therapeutic application
03/02/2000WO2000010995A1 Novel salt form of pantoprazole
03/02/2000WO2000010993A1 Diarylbenzopyran derivatives as cyclooxygenase-2 inhibitors
03/02/2000WO2000010991A1 Inhibition and treatment of hepatitis b virus and flavivirus by helioxanthin and its analogs
03/02/2000WO2000010990A2 Dicationic dibenzofuran and dibenzothiophene compounds and methods of use thereof
03/02/2000WO2000010988A1 Water soluble analogs and prodrugs of paclitaxel
03/02/2000WO2000010982A1 Quinazoline derivatives and pharmaceutical applications therof
03/02/2000WO2000010981A1 Quinazoline derivatives
03/02/2000WO2000010980A1 Pyrimidinone derivatives for the treatment of atherosclerosis
03/02/2000WO2000010975A1 Oxindole derivatives as growth hormone releasers
03/02/2000WO2000010973A2 Oxo-pyridoimidazole-carboxamides: gaba brain receptor ligands
03/02/2000WO2000010968A2 Novel aryl sulphonamide amino acid esters and analogues
03/02/2000WO2000010967A1 Novel aryl sulphonamides and analogues
03/02/2000WO2000010965A2 Quaternary ammonium salts and their use as anti-hiv agents
03/02/2000WO2000010962A1 Chromium l-threonate, process for preparation of the same and their use
03/02/2000WO2000010958A1 Vitamin d3 mimics
03/02/2000WO2000010611A2 Drug targeting
03/02/2000WO2000010610A2 Drug targeting
03/02/2000WO2000010609A1 Targeting of molecules to large vessel endothelium using epcr
03/02/2000WO2000010606A1 Drugs for relieving carbonyl stress and peritoneal dialysates
03/02/2000WO2000010605A2 Preventives or remedies for eye circulatory failure
03/02/2000WO2000010603A1 Compositions and methods for protecting organs, tissue and cells from immune system-mediated damage
03/02/2000WO2000010600A2 Activation and protection of t-cells (cd4+ and cd8+) using an h¿2? receptor agonist and other t-cell activating agents
03/02/2000WO2000010596A1 Method of increasing bone toughness and stiffness and reducing fractures
03/02/2000WO2000010588A2 Epidermal growth factor receptor antagonists for treating hypersecretion of mucus in the lungs
03/02/2000WO2000010586A1 Composition and method for eliminating undigested fat and reducing cholesterol in the human body
03/02/2000WO2000010582A2 Probiotic, lactic acid-producing bacteria and uses thereof
03/02/2000WO2000010576A1 Method of producing means for treating the human body
03/02/2000WO2000010574A1 The use of loop diuretics for hiv infection
03/02/2000WO2000010573A1 Compounds, compositions and methods for treating or preventing viral infections and associated diseases
03/02/2000WO2000010572A1 Use of hydroxyrisperidone for the manufacture of a medicament for the treatment and prevention of psychoses, emesis and symptoms of withdrawal from alcohol and nicotine
03/02/2000WO2000010571A1 Calcium channel antagonists
03/02/2000WO2000010570A1 Aqueous liquid preparations
03/02/2000WO2000010569A1 Nitrogenous heterocyclic carboxamide derivatives or salts thereof and antiviral agents containing both
03/02/2000WO2000010568A1 Methods and compositions for treating periodontal disease with an inhibitor of secretory phospholipase a¿2?
03/02/2000WO2000010567A1 Amelioration of apomorphine adverse effects
03/02/2000WO2000010566A1 Novel isoxazolinone antibacterial agents
03/02/2000WO2000010563A1 Novel substituted triazole compounds
03/02/2000WO2000010562A1 Physically stable and x-ray amorphous form of hydrochloride ranitidine having an increased anti-ulcer activity and method for producing the same
03/02/2000WO2000010561A1 Bio-chemical germanium complexes with high therapeutic efficiency and wide application spectrum
03/02/2000WO2000010560A1 Remedies or preventives containing cyclopentenone compounds as the active ingredient
03/02/2000WO2000010559A1 Inorgasmia treatment
03/02/2000WO2000010558A1 Natural physiologically active substances efficacious against fish diseases and fish feeds containing the same
03/02/2000WO2000010556A1 Use of quaternary nitrogen compounds for prophylaxis or treatment of superinfected atopic eczema
03/02/2000WO2000010555A1 Method of preventing tuberculosis in young cattle
03/02/2000WO2000010554A2 Methods and compositions employing optically pure s(+) vigabatrin
03/02/2000WO2000010553A2 Carbamate and urea compositions and neurotrophic uses
03/02/2000WO2000010552A2 Use of anti-angiogenic agents for inhibiting vessel wall injury
03/02/2000WO2000010551A2 Methods of using and compositions comprising dopamine reuptake inhibitors
03/02/2000WO2000010550A2 Reduction of surfactant inactivation in pulmonary surfactant therapy
03/02/2000WO2000010549A1 Regulation of substrate activity
03/02/2000WO2000010548A2 19-nor-vitamin d3 compounds with calcemic activity
03/02/2000WO2000010547A2 New use of taxoid derivatives
03/02/2000WO2000010546A2 D-arginine for the treatment of neorodegenerative diseases
03/02/2000WO2000010545A2 Use of substance p antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of nk-1 receptor antagonists for the treatment of chronic fatigue syndrome
03/02/2000WO2000010544A2 A method for preventing the onset of asthma
03/02/2000WO2000010543A2 Medicament containing platinum complex compounds and the use thereof
03/02/2000WO2000010542A2 Utilization of pentaerythrityl nitrates together with phosphodiesterase-v-inhibitors, e.g. sildenafil
03/02/2000WO2000010537A1 Timed release tablet comprising naproxen and pseudoephedrine
03/02/2000WO2000010536A1 Extended release buccal bioadhesive tablet
03/02/2000WO2000010534A1 Pharmaceutical composition for injection based on a pharmaceutically acceptable clopidogrel or ticlopidin salt
03/02/2000WO2000010533A2 Compositions and methods for treating intracellular infections
03/02/2000WO2000010532A1 Dinitroaniline liposomal formulations and processes for their preparation
03/02/2000WO2000010531A1 Injectable aqueous dispersions of propofol
03/02/2000WO2000010528A1 Oral liquid mucoadhesive compositions
1 ... 6354 6355 6356 6357 6358 6359 6360 6361 6362 6363 6364 6365 6366 6367 6368 6369 6370 6371 6372 6373 6374 ... 7860